Croucher, P., Shipman, C., Lippitt, J., Perry, M., Asosingh, K., Hijzen, A., . . . Vanderkerken, K. (2001). Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
Cita Chicago (17th ed.)Croucher, P., et al. Osteoprotegerin Inhibits the Development of Osteolytic Bone Disease in Multiple Myeloma. 2001.
Cita MLA (9th ed.)Croucher, P., et al. Osteoprotegerin Inhibits the Development of Osteolytic Bone Disease in Multiple Myeloma. 2001.
Atenció: Aquestes cites poden no estar 100% correctes.